Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
9.94
+0.70 (7.58%)
At close: Sep 28, 2026, 4:00 PM EDT
9.73
-0.21 (-2.11%)
Pre-market: Sep 29, 2026, 4:16 AM EDT
Sagimet Biosciences Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Sagimet Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $29.6. The average 1-year stock price forecast is 197.79% higher than the current stock price, while the lowest is $18 (+81.09%) and the highest is $56 (+463.38%).
Price Target: $29.6 (+197.79%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sagimet Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $31 | Buy | Reiterates | $31 | +211.87% | Sep 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $29 | Buy | Reiterates | $29 | +191.75% | Sep 28, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Initiates $7 | Sell | Initiates | $7 | -29.58% | Sep 24, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $26 | Buy | Initiates | $26 | +161.57% | Sep 9, 2026 |
| Barclays | Barclays | Buy Upgrades $8 → $18 | Buy | Upgrades | $8 → $18 | +81.09% | Sep 9, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
7.37M
EPS This Year
-1.16
from -1.58
EPS Next Year
-1.39
from -1.16
EPS and Forward PE are based on non-GAAP adjusted numbers.